300 related articles for article (PubMed ID: 10505064)
21. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
Meja KK; Barnes PJ; Giembycz MA
Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
[TBL] [Abstract][Full Text] [Related]
22. Identification of a single (FP) receptor associated with prostanoid-induced Ca2+ signals in Swiss 3T3 cells.
Woodward DF; Lawrence RA
Biochem Pharmacol; 1994 Apr; 47(9):1567-74. PubMed ID: 8185669
[TBL] [Abstract][Full Text] [Related]
23. Antinidatory effect of luteal phase administration of mifepristone (RU486) is associated with changes in endometrial prostaglandins during the implantation window.
Nayak NR; Sengupta J; Ghosh D
Contraception; 1998 Aug; 58(2):111-7. PubMed ID: 9773266
[TBL] [Abstract][Full Text] [Related]
24. Prostaglandin E1 and F2alpha specific binding in bovine corpora lutea: comparison with luteolytic effects.
Kimball FA; Lauderdale JW
Prostaglandins; 1975 Aug; 10(2):313-31. PubMed ID: 1178910
[TBL] [Abstract][Full Text] [Related]
25. Studies on the characterisation of prostanoid receptors: a proposed classification.
Kennedy I; Coleman RA; Humphrey PP; Levy GP; Lumley P
Prostaglandins; 1982 Nov; 24(5):667-89. PubMed ID: 6131499
[TBL] [Abstract][Full Text] [Related]
26. [Prostaglandin interaction in the human liver].
Virgolini I; Weiss K; Hermann M; Müller C; Sinzinger H
Klin Wochenschr; 1989 Dec; 67(24):1229-35. PubMed ID: 2483738
[TBL] [Abstract][Full Text] [Related]
27. Characterization of the prostanoid receptors mediating inhibition of PAF-induced aggregation of guinea-pig eosinophils.
Teixeira MM; al-Rashed S; Rossi AG; Hellewell PG
Br J Pharmacol; 1997 May; 121(1):77-82. PubMed ID: 9146890
[TBL] [Abstract][Full Text] [Related]
28. Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells.
Timoshenko AV; Xu G; Chakrabarti S; Lala PK; Chakraborty C
Exp Cell Res; 2003 Oct; 289(2):265-74. PubMed ID: 14499627
[TBL] [Abstract][Full Text] [Related]
29. Fewer PGE2 and PGF2 alpha receptors in brain synaptosomes of newborn than of adult pigs.
Li DY; Varma DR; Chatterjee TK; Fernandez H; Abran D; Chemtob S
J Pharmacol Exp Ther; 1993 Dec; 267(3):1292-7. PubMed ID: 8263792
[TBL] [Abstract][Full Text] [Related]
30. [3H]AL-5848 ([3H]9beta-(+)-Fluprostenol). Carboxylic acid of travoprost (AL-6221), a novel FP prostaglandin to study the pharmacology and autoradiographic localization of the FP receptor.
Sharif NA; Davis TL; Williams GW
J Pharm Pharmacol; 1999 Jun; 51(6):685-94. PubMed ID: 10454045
[TBL] [Abstract][Full Text] [Related]
31. Luteolytic potency of PGD and PGF2 alpha derivatives.
Brambaifa N
Eur J Obstet Gynecol Reprod Biol; 1988 Apr; 27(4):319-25. PubMed ID: 3164283
[TBL] [Abstract][Full Text] [Related]
32. Selected properties of [3H]prostaglandin E1 binding to dispersed bovine luteal cells.
Lin MT; Rao CV
Mol Cell Endocrinol; 1978 Jan; 9(3):311-20. PubMed ID: 203503
[TBL] [Abstract][Full Text] [Related]
33. Roles of the central prostaglandin EP3 receptors in cardiovascular regulation in rats.
Ariumi H; Takano Y; Masumi A; Takahashi S; Hirabara Y; Honda K; Saito R; Kamiya HO
Neurosci Lett; 2002 May; 324(1):61-4. PubMed ID: 11983295
[TBL] [Abstract][Full Text] [Related]
34. Effects of EP-receptor subtype specific agonists and other prostanoids on adenylate cyclase activity of duodenal epithelial cells.
Reimer R; Heim HK; Muallem R; Odes HS; Sewing KF
Prostaglandins; 1992 Nov; 44(5):485-93. PubMed ID: 1361678
[TBL] [Abstract][Full Text] [Related]
35. Characterization of prostaglandin and thromboxane receptors expressed on a megakaryoblastic leukemia cell line, MEG-01s.
Watanabe T; Yatomi Y; Sunaga S; Miki I; Ishii A; Nakao A; Higashihara M; Seyama Y; Ogura M; Saito H
Blood; 1991 Nov; 78(9):2328-36. PubMed ID: 1718495
[TBL] [Abstract][Full Text] [Related]
36. Radioligand binding analysis of receptor subtypes in two FP receptor preparations that exhibit different functional rank orders of potency in response to prostaglandins.
Woodward DF; Fairbairn CE; Krauss AH; Lawrence RA; Protzman CE
J Pharmacol Exp Ther; 1995 Apr; 273(1):285-7. PubMed ID: 7714778
[TBL] [Abstract][Full Text] [Related]
37. Human hepatocellular cancers show decreased prostaglandin E1 binding capacity.
Virgolini I; Sinzinger H; Müller C; Hermann M
Br J Cancer; 1989 Mar; 59(3):407-9. PubMed ID: 2539179
[TBL] [Abstract][Full Text] [Related]
38. Modified LDL decreases the binding of prostaglandin E2, I2, and E1 onto monocytes in patients with peripheral vascular disease.
Li SR; Yang Q; Koller E; Kurtaran A; Bischof C; Leimer M; Rauscha F; Pidlich J; Virgolini I
Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):2066-73. PubMed ID: 9351373
[TBL] [Abstract][Full Text] [Related]
39. Ocular hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding affinities and selectivities, and agonist potencies at FP and other PG receptors in cultured cells.
Sharif NA; Kelly CR; Crider JY; Williams GW; Xu SX
J Ocul Pharmacol Ther; 2003 Dec; 19(6):501-15. PubMed ID: 14733708
[TBL] [Abstract][Full Text] [Related]
40. Specific prostaglandin E2 binding sites in isolated rat glomeruli: evidence for glomerular PGE receptors.
Chaudhari A; Kirschenbaum MA
Prostaglandins Leukot Med; 1985 Oct; 20(1):55-68. PubMed ID: 2866541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
